NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/07/2025
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Filing basis
Drawing code
Owner type
Owner location
Examiner
Current location
Holders
Representatives
Kaitlyn M. Garvin SAUNDERS & SILVERSTEIN LLP
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; chemical preparations for medical use for marking tissue by injection in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable administration, for oral and topical antiseptic treatment, for marking and functional verification of gynecological and urological systems by instillation, injection or local application; injectable pharmaceutical solutions for use as a marker during gastrointestinal endoscopy; injectable pharmaceutical solutions used as a contrast solution for medical imaging procedures; injectable pharmaceutical solutions for medical diagnostic purposes for viewing and marking tissue; injectable pharmaceutical solutions used as an aid in visualization of topographic irregularities and in delineation of polypoid or flat lesions, including adenomas; injectable pharmaceutical solutions used for polyps or lesions resection medicines for tissue staining; injectable pharmaceutical solutions for use as a marker during visceral surgery; injectable pharmaceutical solutions for the detection of amniotic fluid leaks; injectable pharmaceutical solutions for use as a marker during cystoscopy and ureteral catheterization; injectable pharmaceutical solutions for use as a marker during vessel delineation and tumor localization procedures; clinical medical reagents; synthetic peptides for pharmaceutical use, namely, for cancer treatments, immunotherapy, cell therapy, antivirals and antibiotics; phytotherapy preparations for medical use; diagnostic preparations in vials for medical use; drug delivery agents in the form of injectable compounds being pharmaceutical solutions in pre-filled vials that facilitate the delivery of pharmaceutical preparations; pre-filled syringes for medical and clinical purposes, sold filled with injectable pharmaceutical solutions for marking tissue by injection application in surgery and internal medicine, for marking tissue of the digestive system by oral, anal or injectable, for the antiseptic treatment orally or topically, for marking and functional verification gynecological and urological systems, by instillation, injection or local application
History of USPTO decisions and trademark events.
16 publications found
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/07/2025
REGISTERED-PRINCIPAL REGISTER
01/07/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/17/2024
PUBLISHED FOR OPPOSITION
09/17/2024
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/28/2024
APPROVED FOR PUB - PRINCIPAL REGISTER
08/12/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/11/2024
ASSIGNED TO LIE
08/10/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/23/2024
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/16/2024
NON-FINAL ACTION E-MAILED
01/16/2024
NON-FINAL ACTION WRITTEN
01/16/2024
ASSIGNED TO EXAMINER
01/04/2024
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2023
NEW APPLICATION ENTERED
04/11/2023
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.